Anti-angiogenic therapy for lung cancer


Autoria(s): Pavlakis, Nick; Marx, Gavin; White, Shane; Lee, Christopher W.; Khasraw, Mustafa
Data(s)

01/01/2010

Resumo

This is the protocol for a review and there is no abstract. The objectives are as follows:<br /><br />To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo-radiotherapy (in the case of locally advanced non-metastatic NSCLC or limited stage SCLC).

Identificador

http://hdl.handle.net/10536/DRO/DU:30046496

Idioma(s)

eng

Publicador

John Wiley & Sons

Relação

http://dro.deakin.edu.au/eserv/DU:30046496/khasraw-antiangiogenictherapy-2010.pdf

http://dx.doi.org/10.1002/14651858.CD008047

Direitos

2010, The Cochrane Collaboration

Palavras-Chave #angiogenesis #lung cancer #treatment
Tipo

Journal Article